WARNING: This product is for research use only, not for human or veterinary use.
Hodoodo CAT#: H561051
CAS#: 5633-14-7 (HCl)
Description: Benzetimide HCl, also known as EINECS 227-072-8, Spasmentral, and Dioxatrine, is a muscarinic acetylcholine receptor antagonist. Benzetimide HCl has been used to treat neuroleptic-induced parkinsonism. Benzetimide is an enantiomer of dexetimide.
Hodoodo Cat#: H561051
Name: Benzetimide HCl
CAS#: 5633-14-7 (HCl)
Chemical Formula: C23H27ClN2O2
Exact Mass: 398.18
Molecular Weight: 398.931
Elemental Analysis: C, 69.25; H, 6.82; Cl, 8.89; N, 7.02; O, 8.02
Related CAS #: 14051-33-3 (free base) 5633-14-7 (HCl)
Synonym: Benzetimide HCl; Benzetimide Hydrochloride; EINECS 227-072-8; Spasmentral; Dioxatrine
IUPAC/Chemical Name: 3-(1-benzylpiperidin-4-yl)-3-phenylpiperidine-2,6-dione,hydrochloride
InChi Key: XSOOSXRNMDUWEM-UHFFFAOYSA-N
InChi Code: InChI=1S/C23H26N2O2.ClH/c26-21-11-14-23(22(27)24-21,19-9-5-2-6-10-19)20-12-15-25(16-13-20)17-18-7-3-1-4-8-18;/h1-10,20H,11-17H2,(H,24,26,27);1H
SMILES Code: O=C(C(C1=CC=CC=C1)(C2CCN(CC3=CC=CC=C3)CC2)CC4)NC4=O.[H]Cl
Appearance: Solid powder
Purity: >98% (or refer to the Certificate of Analysis)
Shipping Condition: Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
Storage Condition: Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).
Solubility: Soluble in DMSO
Shelf Life: >2 years if stored properly
Drug Formulation: This drug may be formulated in DMSO
Stock Solution Storage: 0 - 4 C for short term (days to weeks), or -20 C for long term (months).
HS Tariff Code: 2934.99.9001
More Info:
Biological target: | |
In vitro activity: | |
In vivo activity: |
Solvent | Max Conc. mg/mL | Max Conc. mM | |
---|---|---|---|
Solubility | |||
DMSO | 32.0 | 80.21 |
The following data is based on the product molecular weight 398.93 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.
Concentration / Solvent Volume / Mass | 1 mg | 5 mg | 10 mg |
---|---|---|---|
1 mM | 1.15 mL | 5.76 mL | 11.51 mL |
5 mM | 0.23 mL | 1.15 mL | 2.3 mL |
10 mM | 0.12 mL | 0.58 mL | 1.15 mL |
50 mM | 0.02 mL | 0.12 mL | 0.23 mL |
Formulation protocol: | |
In vitro protocol: | |
In vivo protocol: |
1: Blankesteijn WM, Siero HL, Rodrigues de Miranda JF, van Megen YJ, Russel FG. Characterization of muscarinic receptors in rat kidney. Eur J Pharmacol. 1993 Jan 4;244(1):21-7. PubMed PMID: 8420789.
2: DeHaven-Hudkins DL, Ford-Rice FY, Allen JT, Hudkins RL. Allosteric modulation of ligand binding to [3H](+)pentazocine-defined sigma recognition sites by phenytoin. Life Sci. 1993;53(1):41-8. PubMed PMID: 8515681.